Related Experiment Video

Updated: Jun 9, 2025

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

14.8K

Thrombotic Disorders in the Newborn

Karyssa Knopoff1, Lorena Ostilla2, Perry Morocco1

  • 1Section of Pediatric Hematology, Oncology and Stem Cell Transplant, Department of Pediatrics, University of Chicago, Chicago, IL.

Neoreviews
|October 31, 2024
PubMed

Insights

Infant coagulation and thrombotic systems differ from adults, with lower hemostatic factors and prenatal influences. Neonatal physiology can cause a procoagulant state, increasing morbidity and mortality from thrombotic disorders.

Area of Science:

  • Pediatrics
  • Hematology
  • Neonatology

Background:

  • Infant coagulation and thrombotic systems exhibit unique physiology distinct from adults.
  • Lower circulation levels of hemostatic factors and prenatal conditions impact infant hemostasis.
  • Neonatal unique physiology can lead to a procoagulant state, increasing morbidity and mortality.

Purpose of the Study:

  • To review the epidemiology, clinical characteristics, diagnosis, management, and etiologies of thrombotic disorders in infants.
  • To discuss the evaluation for hypercoagulation in neonates.
  • To provide a comprehensive overview of infant thrombotic disorders.

Main Methods:

  • Literature review of congenital and acquired thrombotic disorders in infants.
  • Analysis of epidemiological data and clinical characteristics.
  • Discussion of diagnostic and management strategies, including hypercoagulation evaluation.

Main Results:

  • Infants possess fundamentally different coagulation and thrombotic systems compared to older individuals.
  • Prenatal factors and unique neonatal physiology contribute to a procoagulant state.
  • Thrombotic disorders in infants present significant morbidity and mortality risks.

Conclusions:

  • Understanding the unique physiology of infant hemostasis is crucial for managing thrombotic disorders.
  • Comprehensive evaluation and management strategies are necessary to address congenital and acquired thrombotic conditions in neonates.
  • Further research into hypercoagulation evaluation in infants is warranted.

More Related Videos

Author Spotlight: Advancing Neonatal Cardiac Diagnostics with Echocardiography-Derived Blood Speckle Imaging07:13

Author Spotlight: Advancing Neonatal Cardiac Diagnostics with Echocardiography-Derived Blood Speckle Imaging

Published on: December 22, 2023

1.3K
Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

2.8K

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
716
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
624
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
821
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.2K
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
530
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K